DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meprobamate (Meprobamate) - Summary

 
 



MEPROBAMATE SUMMARY

Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.

Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.


See all Meprobamate indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Meprobamate

Strategic program helps families counter depression and anxiety, Australia
Source: Anxiety / Stress News From Medical News Today [2014.07.15]
A new program aimed at reducing the impact of parents' anxiety or depression on the family is being trialled in Australia.

The effect of anxiety, adrenaline and fatigue for a football player - Mexican study of UK players
Source: Sports Medicine / Fitness News From Medical News Today [2014.06.25]
Some of the most common injuries in football players are violent joint sprains and muscle strains in the legs, which are sometimes caused by anxiety and fatigue accumulated after several games in a...

Social behavior tied to activity in specific brain circuit: finding has implications for autism, social anxiety, schizophrenia, depression
Source: Autism News From Medical News Today [2014.06.23]
A team of Stanford University investigators has linked a particular brain circuit to mammals' tendency to interact socially.

With low-dose computed tomography screening, long-term anxiety or distress not a problem
Source: Lung Cancer News From Medical News Today [2014.06.17]
Examination and review of several studies that evaluated patient-centered outcomes for individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer found that screening does...

Anxiety
Source: MedicineNet Anaphylaxis Specialty [2014.06.05]
Title: Anxiety
Category: Diseases and Conditions
Created: 1/31/2005 5:40:00 AM
Last Editorial Review: 6/5/2014 12:00:00 AM

more news >>

Published Studies Related to Meprobamate

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).

more studies >>

Reports of Suspected Meprobamate Side Effects

Toxicity TO Various Agents (28)Respiratory Arrest (15)Cardiac Arrest (15)Accidental Death (14)Drug Abuse (11)Completed Suicide (11)Death (5)Multiple Drug Overdose Accidental (5)Pulmonary Congestion (5)Pulmonary Oedema (4)more >>


Page last updated: 2014-07-15

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014